{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:10:23Z","timestamp":1727842223439},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"DOI":"10.7759\/cureus.70585","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T07:36:49Z","timestamp":1727768209000},"source":"Crossref","is-referenced-by-count":0,"title":["Psychosis to Pancreatitis: A Case Study Exploring the Risks of Hypertriglyceridemia in a Patient Treated With Olanzapine"],"prefix":"10.7759","author":[{"given":"Eduardo D","family":"Espiridion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S","family":"Murdock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo E","family":"Guani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Arshoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"","year":"2013","unstructured":"Diagnostic and statistical manual of mental disorders. DSM-5. American Psychiatric Association, Arlington, VA; 2013. https:\/\/repository.poltekkes-kaltim.ac.id\/657\/1\/Diagnostic%20and%20statistical%20manual%20of%20mental%20disorders%20_...."},{"key":"ref2","article-title":"Atypical antipsychotic agents","author":"Willner K","year":"2024","unstructured":"Willner K, Vasan S, Patel P, Abdijadid S. Atypical antipsychotic agents. StatPearls. StatPearls Publishing, Treasure Island (FL); 2024. 8:2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2021.11.311","article-title":"Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome","volume":"11","author":"DeJongh BM","year":"2021","unstructured":"DeJongh BM. Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome. Ment Health Clin. 2021, 11:311-9. 10.9740\/mhc.2021.11.311","journal-title":"Ment Health Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221079971","article-title":"Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis","volume":"12","author":"He Y","year":"2022","unstructured":"He Y, Fang W, Li Z, et al.. Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis. Ther Adv Psychopharmacol. 2022, 12:20451253221079971. 10.1177\/20451253221079971","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology","volume":"101","author":"Rojo LE","year":"2015","unstructured":"Rojo LE, Gaspar PA, Silva H, Risco L, Arena P, Cubillos-Robles K, Jara B. Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology. Pharmacol Res. 2015, 101:74-85. 10.1016\/j.phrs.2015.07.022","journal-title":"Pharmacol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73983-4","article-title":"Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis","volume":"10","author":"Li R","year":"2020","unstructured":"Li R, Zhang Y, Zhu W, et al.. Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis. Sci Rep. 2020, 10:17028. 10.1038\/s41598-020-73983-4","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36930-y","article-title":"Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance","volume":"9","author":"Li H","year":"2019","unstructured":"Li H, Peng S, Li S, et al.. Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance. Sci Rep. 2019, 9:1582. 10.1038\/s41598-018-36930-y","journal-title":"Sci Rep"},{"key":"ref8","article-title":"SREBP-1c transcription factor and lipid homeostasis: clinical perspective","volume":"68","author":"Ferr\u00e9 P","year":"2007","unstructured":"Ferr\u00e9 P, Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res. 2007, 68:72-82.","journal-title":"Horm Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3193-7","article-title":"Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia","volume":"229","author":"Yan H","year":"2013","unstructured":"Yan H, Chen JD, Zheng XY. Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia. Psychopharmacology (Berl). 2013, 229:1-7. 10.1007\/s00213-013-3193-7","journal-title":"Psychopharmacology (Berl)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618755002","article-title":"Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management","volume":"6","author":"de Pretis N","year":"2018","unstructured":"de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management. United European Gastroenterol J. 2018, 6:649-55. 10.1177\/2050640618755002","journal-title":"United European Gastroenterol J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.11.025","article-title":"Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia","volume":"108","author":"Polymeropoulos MH","year":"2009","unstructured":"Polymeropoulos MH, Licamele L, Volpi S, et al.. Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia. Schizophr Res. 2009, 108:134-42. 10.1016\/j.schres.2008.11.025","journal-title":"Schizophr Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.023903","article-title":"5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats","volume":"9","author":"Martin-Gronert MS","year":"2016","unstructured":"Martin-Gronert MS, Stocker CJ, Wargent ET, et al.. 5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats. Dis Model Mech. 2016, 9:401-12. 10.1242\/dmm.023903","journal-title":"Dis Model Mech"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01086-x","article-title":"Association between glycemic status and the risk of acute pancreatitis: a nationwide population-based study","volume":"15","author":"Cho IR","year":"2023","unstructured":"Cho IR, Han KD, Lee SH, et al.. Association between glycemic status and the risk of acute pancreatitis: a nationwide population-based study. Diabetol Metab Syndr. 2023, 15:104. 10.1186\/s13098-023-01086-x","journal-title":"Diabetol Metab Syndr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi O","year":"2007","unstructured":"Sentissi O, Epelbaum J, Oli\u00e9 JP, Poirier MF. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr Bull. 2007, 34:1189-99. 10.1093\/schbul\/sbm141","journal-title":"Schizophr Bull"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke C","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, et al.. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018, 51:9-62. 10.1055\/s-0043-116492","journal-title":"Pharmacopsychiatry"},{"key":"ref16","unstructured":"Clinical feature. Dyslipidemia & antipsychotic medications: Who is monitoring the lipids?. (2024). Accessed: 2024: https:\/\/www.lipid.org\/node\/1768."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review","volume":"70","author":"Meyer JM","year":"2004","unstructured":"Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res. 2004, 70:1-17. 10.1016\/j.schres.2004.01.014","journal-title":"Schizophr Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/301463-psychosis-to-pancreatitis-a-case-study-exploring-the-risks-of-hypertriglyceridemia-in-a-patient-treated-with-olanzapine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T07:37:10Z","timestamp":1727768230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/301463-psychosis-to-pancreatitis-a-case-study-exploring-the-risks-of-hypertriglyceridemia-in-a-patient-treated-with-olanzapine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.70585","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}